- Home
- GLPI vs NBIX Comparison
GLPI vs NBIX Comparison
Compare GLPI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPI
- NBIX
- Stock Information
- Founded
- GLPI 2013
- NBIX 1992
- Country
- GLPI United States
- NBIX United States
- Employees
- GLPI N/A
- NBIX N/A
- Industry
- GLPI Real Estate Investment Trusts
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLPI Real Estate
- NBIX Health Care
- Exchange
- GLPI Nasdaq
- NBIX Nasdaq
- Market Cap
- GLPI 14.0B
- NBIX 13.1B
- IPO Year
- GLPI N/A
- NBIX 1996
- Fundamental
- Price
- GLPI $47.10
- NBIX $135.45
- Analyst Decision
- GLPI Buy
- NBIX Buy
- Analyst Count
- GLPI 16
- NBIX 23
- Target Price
- GLPI $53.44
- NBIX $165.00
- AVG Volume (30 Days)
- GLPI 1.1M
- NBIX 910.2K
- Earning Date
- GLPI 10-24-2024
- NBIX 02-05-2025
- Dividend Yield
- GLPI 6.45%
- NBIX N/A
- EPS Growth
- GLPI 4.90
- NBIX 97.40
- EPS
- GLPI 2.86
- NBIX 3.73
- Revenue
- GLPI $1,510,960,000.00
- NBIX $2,242,800,000.00
- Revenue This Year
- GLPI N/A
- NBIX $27.07
- Revenue Next Year
- GLPI $5.19
- NBIX $16.60
- P/E Ratio
- GLPI $16.80
- NBIX $36.33
- Revenue Growth
- GLPI 7.33
- NBIX 25.72
- 52 Week Low
- GLPI $41.80
- NBIX $110.95
- 52 Week High
- GLPI $52.60
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- GLPI 26.33
- NBIX 68.12
- Support Level
- GLPI $49.28
- NBIX $125.61
- Resistance Level
- GLPI $50.36
- NBIX $130.48
- Average True Range (ATR)
- GLPI 0.80
- NBIX 2.92
- MACD
- GLPI -0.33
- NBIX 0.72
- Stochastic Oscillator
- GLPI 0.39
- NBIX 69.33
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a real estate investment property trust whose primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The GLPI's portfolio consisted of interests in sixty one gaming and related facilities, the real property associated with thirty four gaming and related facilities operated by PENN, the real property associated with six gaming and related facilities operated by Caesars Entertainment Corporation.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.